RecruitingPhase 1NCT07093255

Safety, PK and PD of FLQ-101 in Premature Neonates

Studying Retinopathy of prematurity

Last synced from ClinicalTrials.gov May 7, 2026

ℹ

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.

Report missing data

Key facts

Sponsor: FELIQS INC.
Intervention: FLQ-101(drug)
Enrollment: 18 enrolled
Eligibility: All sexes
Timeline: 2025 – 2026

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT07093255 on ClinicalTrials.gov

Other trials for Retinopathy of prematurity

Additional recruiting or active studies for the same condition.

RECRUITINGNCT06612541
Point-of-Care Ophthalmic Diagnostic Imaging of Retinopathy of Prematurity
Vanderbilt University Medical Center
ENROLLING BY INVITATIONNANCT07334652
Pain and Comfort in the Examination of Retinopathy of Prematurity
Ataturk University
RECRUITINGNANCT06717412
Efficacy and Safety of Low-dose Conbercept for Retinopathy of Prematurity Therapy
Wang Yusheng
RECRUITINGNCT05558059
Imaging Retinal Vasculature in Infant Eyes
Duke University
ACTIVE NOT RECRUITINGNANCT06109285
Validation of i-ROP DL to Detect More Than Mild ROP
Siloam Vision
RECRUITINGNCT06315556
An Observational Study to Collect Data on How Aflibercept (Eylea) Given Using a Paediatric Dosing Device is Used in Preterm Babies With Retinopathy of Prematurity in the United Kingdom (UK)
Bayer
RECRUITINGNANCT06694103
The Effect of Two Non-Pharmacological Methods on Pain During Retinopathy Examination
Sinem Basdemir
RECRUITINGPHASE3NCT06067958
Intranasal Dexmedetomidine for Pain Management During Screening for Retinopathy of Prematurity
Assaf-Harofeh Medical Center

See all trials for Retinopathy of prematurity →

← Back to all trials